Clinical trial
A Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression.
NCT03320304 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression.
- Lead sponsor
- LivaNova
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 14, 2017
- Completion date
- December 1, 2031
- Enrollment
- 500 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
treatment resistant depression